DEFENDER CAPITAL, LLC. – Lineage Cell Therapeutics, Inc. Transaction History
DEFENDER CAPITAL, LLC. portfolio value:
$5.86M
portfolio value
DEFENDER CAPITAL, LLC. quarter portfolio value change:
-28.48%
quarter
Lineage Cell Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +1.02% | 52.1K shares | -2.24M | $1.13 | 5.18M |
| Q2 2022 | share | Increase | +2.51% | 125.75K shares | 125K | $1.58 | 5.13M |
| Q1 2022 | share | Increase | +0.17% | 8.31K shares | -4.26M | $1.54 | 5.00M |
| Q4 2021 | share | Increase | +4.16% | 199.6K shares | -462K | $2.5 | 4.99M |
| Q3 2021 | share | Decrease | -4.73% | -238.45K shares | -1.64M | $2.52 | 4.79M |
| Q2 2021 | share | Increase | +1.74% | 86K shares | 2.73M | $2.85 | 5.03M |
| Q1 2021 | share | Increase | +4.53% | 214.73K shares | 3.28M | $2.35 | 4.95M |
| Q4 2020 | share | Decrease | -6.20% | -313K shares | 3.60M | $1.76 | 4.73M |
| Q3 2020 | share | Increase | +8.67% | 402.7K shares | 687K | $0.94 | 5.04M |
| Q2 2020 | share | Increase | +5.20% | 229.7K shares | 385K | $0.87 | 4.64M |
| Q1 2020 | share | Increase | +11.05% | 439.54K shares | 117K | $0.83 | 4.41M |
| Q4 2019 | share | Increase | +4.82% | 183K shares | -169K | $0.89 | 3.97M |
| Q3 2019 | share | Increase | 0.00% | 3.79M shares | 3.70M | $0.98 | 3.79M |